Spinal Manual Therapy for Non-Spinal Musculoskeletal Disorders
Customize your policy alerts
Sign up for orthonet Policy 490 alerts
Get alerted when Policy 490 changes without checking for updates manually.
Monitor payer policy activity
Defines OrthoNet/Optum's position that spinal manipulation or mobilization is unproven and not medically necessary for treating non-spinal musculoskeletal conditions; applies to providers and utilization management within the plan.
No material clinical or coverage changes in this revision.
Coverage Criteria: Spinal Manual Therapy for Non‑Spinal MSD
Coverage stance
Covered when ALL of the following are met
Policy statement declares spinal manual therapy (manipulation or mobilization) directed at spinal structures is unproven and not medically necessary for non-spinal musculoskeletal disorders; no positive coverage criteria are provided.
Not medically necessary
Coverage determination
Conclusion based on limited, low-quality research and inability to demonstrate greater benefit or reduced risk versus generally accepted rehabilitation treatments; further research is needed before this can be considered an established treatment option.
This policy specifically excludes the use of spinal manual therapy for management of referred or radicular symptoms that arise from spine-related disorders (for example, herniated disc or spinal stenosis).
Use of spinal manual therapy for non-spinal musculoskeletal disorders (head/face, upper or lower extremities) is not an established treatment option and is excluded from medically necessary services pending further supporting research.
Spinal manual therapy for the treatment of non-spinal musculoskeletal disorders is considered unproven and not medically necessary due to insufficient scientific evidence of effectiveness.
In summary, spinal manipulation or mobilization directed at the spine for non-spinal musculoskeletal conditions is viewed as unproven and therefore not medically necessary until further research demonstrates clinical benefit.
Provider Actions, Prior Authorization, and Billing Guidance
Prior authorization is subject to utilization management; authorization unlikely
Prior authorization requests for spinal manual therapy (SMT) used to treat non-spinal musculoskeletal disorders are subject to utilization management determinations; because the policy considers SMT for these indications unproven and not medically necessary, authorization is unlikely.
Prior authorization not supported for non-spinal MSD indications
Prior authorization for spinal manual therapy to treat non-spinal musculoskeletal disorders will not be supported because the policy views this use as unproven and not medically necessary.
Use alternatives: extraspinal manual therapy and exercise
Differentiate spinal SMT from extraspinal (local) manual therapy: this policy applies only to spinal-directed manipulation or mobilization, while local extraspinal manual therapy and exercise are addressed separately and are the recommended alternatives.
- SMT is manipulation or mobilization of spinal structures; extraspinal/local manual therapy is covered under a separate policy.
- Consider local (extraspinal) manual therapy and exercise as alternatives before SMT for non-spinal conditions.
Prefer established rehabilitation and safe accepted treatments first
Pursue generally accepted, safe treatments (for example, traditional rehabilitation procedures) as comparators; the work group could not show SMT provided greater benefit or less risk than these established rehabilitation options.
- Providers should pursue established rehabilitation options prior to considering spinal manual therapy for non-spinal conditions.
Document indication and rationale when claiming SMT for non-spinal MSD
Document the indication clearly when spinal manual therapy is used for a non-spinal musculoskeletal disorder (head/face, upper or lower extremity) and include the clinical rationale if SMT is attempted despite the policy's stance that it is unproven for these indications.
- Record the specific non-spinal MSD being treated (anatomic site and diagnosis).
- Include clinical justification and prior conservative treatments tried, if any, given the policy view that SMT is unproven for these uses.
Evidence review: clinician work group systematic review and ratings
Policy conclusions were based on a clinician work group's systematic review of the literature: internet searches, independent examination of selected research, and use of a standard rating scale with possible ratings of proven benefit, potential but unproven benefit, and no proven benefit; documentation of the evidence review should be available on request.
- Work group reviewed selected studies and applied a broadly accepted rating scale.
- Policy underwent committee review including independent practitioners before approval.
Denial risk: billing SMT for non-spinal MSD may be denied
Services billed as spinal manual therapy for the treatment of non-spinal musculoskeletal disorders risk denial because the policy explicitly considers SMT for these indications unproven and not medically necessary.
- Do not bill spinal SMT for non-spinal MSD without recognizing that such claims may be denied under this policy.
Denial risk for unproven treatment: SMT for non-spinal MSD
Claims for spinal manual therapy to treat non-spinal musculoskeletal disorders are viewed as requests for an unproven treatment and therefore risk denial until further research supports its use as an established option.
- Anticipate denial risk for services characterized as unproven or not medically necessary per the policy conclusion.
Background and Context
Spinal manual therapy (manipulation and mobilization) is sometimes used adjunctively for non-spinal musculoskeletal disorders based on the concept of regional interdependence, which proposes that dysfunction in the spine may influence remote regions. Proposed mechanisms include biomechanical effects (such as increased range of motion) and neurophysiologic effects (such as short-term hypoalgesia), but the clinical effectiveness of spinal manual therapy for non-spinal MSD remains uncertain and evidence is insufficient to support routine use.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.